GCTK ▲ +3.7% - GlucoTrack, Inc. $GCTK Lokahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions GlucoTrack rose 3.7% today following an announcement that its Lokahi Therapeutics subsidiary is expanding its ai² technology platform across three new business divisions, a move the market appears to view as a strategic growth opportunity. 08-SEP-2026 09:15 AM ET